GMRE vs. DEI, FCPT, EQC, AHR, DRH, CXW, GNL, PEB, AKR, and IVT
Should you be buying Global Medical REIT stock or one of its competitors? The main competitors of Global Medical REIT include Douglas Emmett (DEI), Four Corners Property Trust (FCPT), Equity Commonwealth (EQC), American Healthcare REIT (AHR), DiamondRock Hospitality (DRH), CoreCivic (CXW), Global Net Lease (GNL), Pebblebrook Hotel Trust (PEB), Acadia Realty Trust (AKR), and InvenTrust Properties (IVT). These companies are all part of the "real estate investment trusts" industry.
Douglas Emmett (NYSE:DEI) and Global Medical REIT (NYSE:GMRE) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership.
Douglas Emmett currently has a consensus target price of $13.67, suggesting a potential upside of 1.23%. Global Medical REIT has a consensus target price of $11.25, suggesting a potential upside of 24.86%. Given Douglas Emmett's stronger consensus rating and higher probable upside, analysts plainly believe Global Medical REIT is more favorable than Douglas Emmett.
Global Medical REIT has lower revenue, but higher earnings than Douglas Emmett. Douglas Emmett is trading at a lower price-to-earnings ratio than Global Medical REIT, indicating that it is currently the more affordable of the two stocks.
Douglas Emmett pays an annual dividend of $0.76 per share and has a dividend yield of 5.7%. Global Medical REIT pays an annual dividend of $0.84 per share and has a dividend yield of 9.3%. Douglas Emmett pays out -245.2% of its earnings in the form of a dividend. Global Medical REIT pays out 365.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Global Medical REIT has raised its dividend for 2 consecutive years. Global Medical REIT is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
In the previous week, Douglas Emmett had 5 more articles in the media than Global Medical REIT. MarketBeat recorded 5 mentions for Douglas Emmett and 0 mentions for Global Medical REIT. Global Medical REIT's average media sentiment score of 0.92 beat Douglas Emmett's score of 0.00 indicating that Douglas Emmett is being referred to more favorably in the media.
Global Medical REIT has a net margin of 13.77% compared to Global Medical REIT's net margin of -5.40%. Douglas Emmett's return on equity of 3.54% beat Global Medical REIT's return on equity.
Douglas Emmett has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Global Medical REIT has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.
97.4% of Douglas Emmett shares are owned by institutional investors. Comparatively, 57.5% of Global Medical REIT shares are owned by institutional investors. 14.7% of Douglas Emmett shares are owned by company insiders. Comparatively, 8.2% of Global Medical REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Douglas Emmett received 117 more outperform votes than Global Medical REIT when rated by MarketBeat users. However, 63.57% of users gave Global Medical REIT an outperform vote while only 59.94% of users gave Douglas Emmett an outperform vote.
Summary
Global Medical REIT beats Douglas Emmett on 13 of the 20 factors compared between the two stocks.
Get Global Medical REIT News Delivered to You Automatically
Sign up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GMRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Global Medical REIT Competitors List
Related Companies and Tools